News | TCTAP 2021 Virtual

Percutaneous Treatment Considerations for Functional Mitral Regurgitation

Samir R. Kapadia, MD (Cleveland Clinic, Ohio, USA) discussed functional mitral regurgitation (MR) treatment considerations while sharing his experience with MitraClip Implant during a session at TCTAP 2021 Virtual that ran from April 21 to 24.

News | TCTAP 2021 Virtual

Chaos in Procedural MI (PMI) Definitions in PCI vs CABG Trials: How to Reconcile?

Patrick W. Serruys (NUI Galway, Ireland), examined the unresolved chaos regarding procedural MI (PMI) definition in PCI vs CABG trials during a session at TCTAP 2021 Virtual, suggesting possible upheaval of PMI definitions altogether.

News | TCTAP & AP VALVES 2020 Virtual

Choice of Stent Platforms in HBR Patients - Insights from the ONYX-ONE Trial

August 8th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL

News | TCTAP & AP VALVES 2020 Virtual

A New Algorithm from Japanese CTO-PCI Expert Registry

August 8th, Highlight Session of TCTAP & AP VALVES 2020 VIRTUAL

News | TCTAP & AP VALVES 2020 Virtual

Cardiac Surgeon David Taggart, Interventional Cardiologist Seung-Jung Park Face Off in CABG Vs. PCI Debate

Park says “LMCAD is no longer a surgical disease” while Taggart rebuts “CABG a clear winner in left main”

News | TCTAP & AP VALVES 2020 Virtual

Gregg Stone Emphasizes No PCI, CABG Difference for Long-Term Survival of LMCAD

Mount Sinai Heart Health System Director Gregg W. Stone, MD explains EXCEL controversy, heart team approach for PCI, CABG in LMCAD at TCTAP & AP VALVES 2020 VIRTUAL

News | TCTAP & AP VALVES 2020 Virtual

Global Experts Convene on COVID-19 Vaccine Timeline

Cedars-Sinai Medical Center Jonathan Grein, WRAIR Kayvon Modjarrad deliver special COVID-19 treatment and vaccine talks at TCTAP & AP VALVES 2020 VIRTUAL